Meeting
2014 ASCO Annual Meeting
Reverse phase protein microarray for identification of IL6 receptor ligation-induced insulin receptor, PI3K/AKT, and JAK/STAT signaling pathways in the CARD11 mutated lymphoma cell line OCI-Ly3.
Authors
Greg Coffey
Portola Pharmaceuticals, Inc., South San Francisco, CA
Greg Coffey , Akiko Futamura , Shruti Shrivastav , Yoshinori Tanizawa , Takeomi Inoue , Naoko Iwata , Yasuyuki Kirii , Pamela Conley , Anjali Pandey
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lymphoma and Plasma Cell Disorders
Track
Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia
Sub Track
Lymphoma
Citation
J Clin Oncol 32:5s, 2014 (suppl; abstr 8574)
DOI
10.1200/jco.2014.32.15_suppl.8574
Abstract #
8574
Poster Bd #
261
Abstract Disclosures
Similar Posters
Poster
2014 ASCO Annual Meeting
Antitumor activity of inhibiting SYK kinase with TAK-659, an investigational agent, in DLBCL models.
First Author: Jessica Huck
First Author: Kimberly Stephanie Meza
Poster
2022 ASCO Genitourinary Cancers Symposium
Targeting an IL-6/JAK/STAT/PIM1 pathway in renal cell carcinoma.
First Author: Kimberly Stephanie Meza
Poster
2019 ASCO Annual Meeting
Molecular profiling of primary central nervous system lymphoma as compared to activated B-cell subtype of diffuse large B-cell lymphoma.
First Author: Mohamad Barakat